State of Alaska Department of Revenue’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.5M Buy
19,965
+2,640
+15% +$1.39M 0.11% 157
2025
Q1
$11M Buy
17,325
+325
+2% +$206K 0.12% 148
2024
Q4
$12.1M Sell
17,000
-2,294
-12% -$1.63M 0.14% 129
2024
Q3
$20.3M Sell
19,294
-1,505
-7% -$1.58M 0.22% 77
2024
Q2
$21.9M Sell
20,799
-440
-2% -$462K 0.25% 66
2024
Q1
$20.4M Sell
21,239
-1,895
-8% -$1.82M 0.23% 72
2023
Q4
$20.3M Sell
23,134
-210
-0.9% -$184K 0.24% 69
2023
Q3
$19.2M Sell
23,344
-690
-3% -$568K 0.24% 68
2023
Q2
$17.3M Sell
24,034
-11,780
-33% -$8.46M 0.21% 83
2023
Q1
$29.4M Sell
35,814
-191
-0.5% -$157K 0.35% 47
2022
Q4
$26M Buy
36,005
+4,267
+13% +$3.08M 0.32% 50
2022
Q3
$21.9M Sell
31,738
-12,864
-29% -$8.86M 0.29% 59
2022
Q2
$26.4M Buy
44,602
+18,137
+69% +$10.7M 0.32% 52
2022
Q1
$18.5M Buy
26,465
+3,575
+16% +$2.5M 0.19% 98
2021
Q4
$14.5M Buy
22,890
+4,669
+26% +$2.95M 0.14% 146
2021
Q3
$11M Buy
18,221
+202
+1% +$122K 0.11% 207
2021
Q2
$10.1M Sell
18,019
-9,911
-35% -$5.54M 0.1% 234
2021
Q1
$13.2M Sell
27,930
-1,374
-5% -$650K 0.14% 164
2020
Q4
$14.2M Sell
29,304
-1,359
-4% -$656K 0.16% 142
2020
Q3
$17.2M Sell
30,663
-5,681
-16% -$3.18M 0.21% 96
2020
Q2
$22.7M Buy
36,344
+22,607
+165% +$14.1M 0.29% 62
2020
Q1
$6.71M Buy
13,737
+605
+5% +$295K 0.11% 256
2019
Q4
$4.93M Sell
13,132
-1,090
-8% -$409K 0.06% 387
2019
Q3
$3.95M Buy
14,222
+1,444
+11% +$401K 0.05% 419
2019
Q2
$4M Sell
12,778
-317
-2% -$99.2K 0.07% 333
2019
Q1
$5.38M Sell
13,095
-246
-2% -$101K 0.1% 242
2018
Q4
$4.98M Sell
13,341
-73
-0.5% -$27.3K 0.1% 235
2018
Q3
$5.42M Sell
13,414
-326
-2% -$132K 0.09% 245
2018
Q2
$4.74M Buy
13,740
+2,650
+24% +$914K 0.08% 268
2018
Q1
$3.82M Buy
11,090
+1,780
+19% +$613K 0.08% 296
2017
Q4
$3.5M Buy
9,310
+8,050
+639% +$3.02M 0.08% 275
2017
Q3
$563K Buy
+1,260
New +$563K 0.03% 667